Ness Therapeutics

Currently, interventions surrounding known virus infections focus on treatment: to accelerate viral clearance and to reduce symptoms. Ness Therapeutics aspires to transform the respiratory virus infection drug market from “treatment to cure” to “protection from infection” via prophylactic application for known and newly emerging viruses. Our vision is to revolutionize the respiratory virus infection drug market, shifting the focus from mere treatment to proactive protection through prophylactic interventions for both known and newly emerging, unidentified viruses. We aim to disrupt conventional methods such as vaccines and pathogen-targeted therapeutics, drawing inspiration from our innate immune system. By establishing a virus-agnostic strategy, our goal is to block transmission from infected individuals, ushering in a new era of virus control.